Description

BSE lists 72,50,000 new equity shares of Sarda Proteins Ltd issued on preferential basis via warrant conversion, effective May 12, 2026. Majority shares are subject to lock-in until November 2027.

Summary

BSE has listed 72,50,000 new equity shares of Sarda Proteins Ltd (Scrip Code: 519242) effective Tuesday, May 12, 2026. The shares were issued at Rs. 115/- each (face value Rs. 10/- + premium Rs. 105/-) to Promoters and Non-Promoters on a preferential basis pursuant to conversion of warrants. These shares rank pari-passu with the existing equity shares of the company.

Key Points

  • 72,50,000 equity shares of Rs. 10/- face value issued at Rs. 115/- (Rs. 105/- premium) via preferential allotment
  • Allotment was made to both Promoter and Non-Promoter categories through conversion of warrants
  • Distribution numbers: 1725901 to 8975900
  • Date of allotment: March 18, 2026
  • ISIN: INE995U01011
  • Shares are pari-passu with existing equity shares
  • Trading permitted from May 12, 2026

Regulatory Changes

No new regulatory changes introduced. This is a standard listing notice under BSE’s Listing Operations framework for newly allotted securities.

Compliance Requirements

  • Trading members are informed to permit trading of the newly listed shares from May 12, 2026
  • Lock-in restrictions must be observed by holders of the locked-in shares as per the details below

Important Dates

  • Date of Allotment: March 18, 2026
  • Effective Trading Date: May 12, 2026 (Tuesday)
  • Lock-in Expiry (72,20,000 shares): November 17, 2027 — Distribution Nos. 1725901 to 8945900
  • Lock-in Expiry (30,000 shares): November 17, 2026 — Distribution Nos. 8945901 to 8975900

Impact Assessment

The listing adds 72,50,000 new shares to Sarda Proteins Ltd’s equity base, expanding the total outstanding share count. However, the near-total lock-in (72,20,000 out of 72,50,000 shares locked until November 2027) significantly limits immediate free-float impact. Only 30,000 shares are subject to the shorter lock-in expiring November 2026. The preferential allotment at Rs. 115/- per share reflects the company’s capital-raising activity through warrant conversion, which may signal ongoing business expansion or debt restructuring.

Impact Justification

Routine preferential allotment listing for a relatively small-cap company; large lock-in period limits immediate trading float impact, but the 7.25 million new shares expand total equity.